Cadrenal Therapeutics (CVKD.BOATS) Q2 2026 Earnings

May 7Confirmed
Q4 2025
Q2 2026
-1.55
-1.38
-1.21
-1.04

Details

Expected EPS
-1.51
Actual EPS
-1.04
Surprise EPS
0.47
Surprise Percent
+31.13%

Description

⁨Cadrenal Therapeutics⁩ (⁦CVKD.BOATS⁩) has reported earnings of ⁦-1.04⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts